FDA Inspection 1021137 — American Red Cross-Myrtle Beach

American Red Cross-Myrtle Beach — FEI 3000207047

The FDA completed an inspection of American Red Cross-Myrtle Beach on August 2, 2017 in Myrtle Beach, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 2, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Myrtle Beach, SC (United States)